Article

An American Journal of Managed Care® Patient Perspective: Treating Idiopathic Pulmonary Fibrosis

https://www.pharmacytimes.org/landing/1056

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!
Related Videos
Frank Weinberg, MD, PhD
Dr James Chalmers
Related Content
Overall, participants with CLL had significantly lower MLR values compared with the healthy donors. | Image credit: angellodeco - stock.adobe.com
August 23rd 2025

Monocyte-to-Lymphocyte Ratio Linked With Functional Status in CLL

Jared Kaltwasser
The Breakdown: Breast Cancer Research Awareness Day
August 23rd 2025

The Breakdown: Breast Cancer Research Awareness Day

Sabrina McCrear
The results of the study show that synthetic data could maintain accuracy down to 25% of the original real-world data sample size. | Image credit: tippapatt - stock.adobe.com
August 23rd 2025

Smaller Trials, Bigger Impact: The Potential of Synthetic Data in CSU

Kimberly Rath, PharmD
managed care cast banner
August 23rd 2025

Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD

Mary Caffrey Skylar Jeremias Joseph Mikhael, MD
Drug costs in US | Image Credit: Kenishirotie - stock.adobe.com
August 23rd 2025

Patent Extensions Cost US $3.5 Billion in Delayed Generic Savings

Pearl Steinzor
Florida Flooding | Image credit: bilanol - stock.adobe.com
August 23rd 2025

Increased Odds of Depression, Anxiety in Adults Displaced by Natural Disaster

Julia Bonavitacola

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo